Furthermore, targeting STAT3 bolsters dendritic cell (DCs) activation, augments macrophage recognition and phagocytosis in HCC cells, and cultivates anti-HCC immune memory, along with the accumulation of key anti-tumor effector CD8 + T cells within the TME [79] (Fig. 5). This evidence concerns the gene CD8A and hepatocellular carcinoma.